Statistics for Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Total visits

views
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study 0

Total visits per month

views
April 2024 0
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0

File Visits

views
40425_2018_Article_420.pdf 31